Literature DB >> 33097617

Prescription of proton pump inhibitors in older adults with complex polytherapy.

Clara Cena1, Sara Traina2, Beatrice Parola2, Mario Bo3, Riccardo Fagiano3, Carlotta Siviero2.   

Abstract

OBJECTIVES: Prescription of proton pump inhibitors (PPIs) may be a source of potentially clinically relevant drug-drug interactions (DDIs) and related complications for elderly patients with complex polytherapy at discharge from hospital. The aim of the study was to identify, through the analysis of hospital discharge records, the co-administrations (PPIs + one or more drugs potentially generating DDIs) hypothetically leading to severe consequences according to the literature and online databases. Subsequently, alternatives to PPIs were evaluated for the treatment of gastric acidity and ulcers.
METHODS: The medical records of 1288 patients, discharged from a geriatric ward at the Città della Salute e della Scienza Hospital in Turin from January 2012 to December 2013, were collected in an Excel database for analysis of DDIs using the literature and online sources such as Micromedex. RESULTS : Six hundred and sixty-three of the 1288 clinical folders had a PPI prescription. A list of 18 drugs considered potentially hazardous and able to trigger a DDI when co-administrated with PPIs was drafted; the frequencies of the co-prescriptions of each PPI with one of the listed drugs were esomeprazole 65.38%, lansoprazole 52.87%, omeprazole 48.19% and pantoprazole 37.11%. An analysis of these co-prescriptions, according to Micromedex classification, gave a percentage of major interactions of 11.01% over 663 clinical folders including a PPI.
CONCLUSIONS: This study provides a collection of potentially hazardous drug associations and helpful suggestions to improve the quality of prescriptions for elderly patients and strengthens the case for synergic work between doctors and pharmacists in the wards. © European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  co-administration; drug-drug interactions; elderly; polytherapy; proton-pump inhibitor

Year:  2019        PMID: 33097617      PMCID: PMC7856130          DOI: 10.1136/ejhpharm-2018-001697

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  27 in total

1.  Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.

Authors:  J W Ko; N Sukhova; D Thacker; P Chen; D A Flockhart
Journal:  Drug Metab Dispos       Date:  1997-07       Impact factor: 3.922

2.  Examining the potential relationship between proton pump inhibitor use and the risk of bone fracture.

Authors:  David C Metz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

3.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection.

Authors:  Amy Linsky; Kalpana Gupta; Elizabeth V Lawler; Jennifer R Fonda; John A Hermos
Journal:  Arch Intern Med       Date:  2010-05-10

4.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

5.  Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards.

Authors:  Evelyn P M van Vliet; Henk J A M Otten; Arjan Rudolphus; Pieter D Knoester; Henk C Hoogsteden; Ernst J Kuipers; Peter D Siersema
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-07       Impact factor: 2.566

6.  Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward.

Authors:  Pieter Cornu; Stephane Steurbaut; Sabina Soštarić; Aleš Mrhar; Alain G Dupont
Journal:  Int J Clin Pharm       Date:  2014-02-25

7.  We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.

Authors:  Angel Lanas
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

8.  Prevalence, predictors and clinical impact of potentially inappropriate prescriptions in hospital-discharged older patients: A prospective study.

Authors:  Mario Bo; Valeria Quaranta; Gianfranco Fonte; Yolanda Falcone; Giulia Carignano; Giorgetta Cappa
Journal:  Geriatr Gerontol Int       Date:  2017-12-19       Impact factor: 2.730

Review 9.  Systematic review: hypomagnesaemia induced by proton pump inhibition.

Authors:  M W Hess; J G J Hoenderop; R J M Bindels; J P H Drenth
Journal:  Aliment Pharmacol Ther       Date:  2012-07-04       Impact factor: 8.171

10.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262

View more
  2 in total

1.  Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults.

Authors:  Erik Puchon; Maria Goboova; Ivan Vano; Tomas Fazekas; Zuzana Javorova-Rihova; Magdalena Kuzelova
Journal:  Eur Geriatr Med       Date:  2020-08-17       Impact factor: 1.710

2.  Prescription Habits Related to Chronic Pathologies of Elderly People in Primary Care in the Western Part of Romania: Current Practices, International Recommendations, and Future Perspectives Regarding the Overuse and Misuse of Medicines.

Authors:  Valentina Buda; Andreea Prelipcean; Carmen Cristescu; Alexandru Roja; Olivia Dalleur; Minodora Andor; Corina Danciu; Adriana Ledeti; Cristina Adriana Dehelean; Octavian Cretu
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.